Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

Journal of Steroid Biochemistry and Molecular Biology

Volumn 37, Issue 6, 1990, Pages 811-814

  Nicholson, Stewart ^a   Wright, Christopher ^a   Richard C Sainsbury, J ^a   Halcrow, Pauline ^a   Kelly, Peter ^a   Angus, Brian ^a   FarnVon, John R ^a   Harris, Adrian L ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; TAMOXIFEN;

BREAST CANCER; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; EPIDERMAL GROWTH FACTOR; FEMALE; GREAT BRITAIN; HUMAN; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; TAMOXIFEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0025615818     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(90)90424-J     Document Type: Article

References (16)

1. Patterns of relapse and survival following radical mastectomy: analysis of 716 consecutive patients
2. Ten year follow-up results of patients with carinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy
3. Five year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer
4. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative tumour
5. Oestrogen receptors and prognosis in early breast cancer
6. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node-negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project B-06
7. Epidermal growth factor receptors and oestrogen receptors in human breast cancer
8. Epidermal growth factor receptors in human breast cancer
9. Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer
10. Receptors for epidermal growth factor and estrogen as predictors of relapse in patients with mammary carcinoma
11. Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer
12. Quantitative assays of epidermal growth factor receptor in human breast cancer: Cut off points of clinical relevance
13. Expression of C-erbB-2 oncoprotein: a prognostic marker in human breast cancer
14. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II Analysis and examples
15. Regression models and life tables
16. Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer